An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug – Paxlovid – is intended for use soon after symptoms develop in people at high risk of severe disease.
Pfizer says it stopped trials early as the initial results were so positive.
It comes the day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
Please subscribe HERE http://bit.ly/1rbfUog
#Covid #BBCNews
Politica. Governo studia contributo una tantum da assicurazioni, banche e aziende settore energetico. Studio Unimpresa. Antonio Tajani (FI) resta contrario.…
MILANO (ITALPRESS) – Il derby di Milano torna rossonero, con il Milan che batte per 2-1 l’Inter e interrompe la…
The United Nations is warning that the Middle East is on the brink of imminent catastrophe, with fears of escalation…
Left-leaning politician Anura Kumara Dissanayake has won Sri Lanka’s presidential election after a historic second round of counting. He heads…
ROMA (ITALPRESS) – La nuova Roma di Ivan Juric travolge per 3-0 l’Udinese nel match dell’Olimpico valevole per la quinta…